Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.

In individuals with IFG, information from three clinical variables easily obtained in the clinical setting showed a good prediction of regression to normoglycemia beyond metabolomic features. Our findings can serve to inform and design future cardiovascular prevention strategies.